These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 12356320

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Loop-loop interaction of HIV-1 TAR RNA with N3'-->P5' deoxyphosphoramidate aptamers inhibits in vitro Tat-mediated transcription.
    Darfeuille F, Arzumanov A, Gryaznov S, Gait MJ, Di Primo C, Toulmé JJ.
    Proc Natl Acad Sci U S A; 2002 Jul 23; 99(15):9709-14. PubMed ID: 12105271
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. NMR structure of a kissing complex formed between the TAR RNA element of HIV-1 and a LNA-modified aptamer.
    Lebars I, Richard T, Di Primo C, Toulmé JJ.
    Nucleic Acids Res; 2007 Jul 23; 35(18):6103-14. PubMed ID: 17768146
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Exploring TAR-RNA aptamer loop-loop interaction by X-ray crystallography, UV spectroscopy and surface plasmon resonance.
    Lebars I, Legrand P, Aimé A, Pinaud N, Fribourg S, Di Primo C.
    Nucleic Acids Res; 2008 Dec 23; 36(22):7146-56. PubMed ID: 18996893
    [Abstract] [Full Text] [Related]

  • 10. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
    Wu F, Garcia J, Sigman D, Gaynor R.
    Genes Dev; 1991 Nov 23; 5(11):2128-40. PubMed ID: 1936997
    [Abstract] [Full Text] [Related]

  • 11. Hexitol nucleic acid-containing aptamers are efficient ligands of HIV-1 TAR RNA.
    Kolb G, Reigadas S, Boiziau C, van Aerschot A, Arzumanov A, Gait MJ, Herdewijn P, Toulmé JJ.
    Biochemistry; 2005 Mar 01; 44(8):2926-33. PubMed ID: 15723535
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation.
    Bohjanen PR, Liu Y, Garcia-Blanco MA.
    Nucleic Acids Res; 1997 Nov 15; 25(22):4481-6. PubMed ID: 9358155
    [Abstract] [Full Text] [Related]

  • 16. In vitro selection of RNA aptamers derived from a genomic human library against the TAR RNA element of HIV-1.
    Watrin M, Von Pelchrzim F, Dausse E, Schroeder R, Toulmé JJ.
    Biochemistry; 2009 Jul 07; 48(26):6278-84. PubMed ID: 19496624
    [Abstract] [Full Text] [Related]

  • 17. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L, Morris GF, Lockyer JM, Lu M, Wang Z, Morris CB.
    Virology; 1997 Aug 18; 235(1):48-64. PubMed ID: 9300036
    [Abstract] [Full Text] [Related]

  • 18. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
    Arzumanov A, Stetsenko DA, Malakhov AD, Reichelt S, Sørensen MD, Babu BR, Wengel J, Gait MJ.
    Oligonucleotides; 2003 Aug 18; 13(6):435-53. PubMed ID: 15025911
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.